Company description: OXB is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, OXB has more than 30 years of experience in viral vectors, the driving force behind the majority of gene therapies. Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patients cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy). OXB collaborates with some of the worlds most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXBs world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise. Job description: Join Us in Changing Lives At?OXB, our people are at the heart of everything we do.Wereon a mission to enable life-changing therapies to reach patients around the worldandwerelooking for passionateindividuals who embody our core values every day:?Responsible, Responsive, Resilient, and Respectful. Were currently recruiting for a? Project/Programme Manager to join ourCommercialteam. In this role, you willbemanagingthe relationship between OXB and its Clients and ensure projects are delivered on time and within budget to the required quality to ensure successful long-term alliances, playing akey rolein advancing our mission and making a real difference. We are happy to consider applications from aspiring Project Managers with proven competency of delivering on Client Projects within this field. We are also able to consider?flexible home working arrangements?combined with some on-site presence. Your responsibilities in this role would be: Maintains client / partner satisfaction to ensure successful long-term alliances. Understands client needs and identifies ongoing project opportunities. Ensures projects are delivered within the agreed scope, timeline and budget and project milestones are met. Ensures project risks areidentified,and effective mitigation actions are put in place. Provides project updates and performance data toOXBManagement to enable effective strategic and tactical decision making. Responsible for all financial aspects of the collaboration including forecasting, costcontroland invoicingetc. Determinesscope, costings, and timelines for new work packages. Assistswith preparing proposals and contributes to contract negotiations for prospective clients. Profile description: We are looking for: Scientific Degree or PhD. Project Management qualification preferred. Demonstrable experience using Project Management tools, methodologies & techniques. Significant project management experience inclusive of budgetary ownership, preferably within the pharmaceutical /biotech industry. Good technical understanding of biopharmaceutical process development andGMPmanufacturing. Experience of working to external client deliverables. Line management experience preferred but not essential. Experience of managing projects usingMSProject & MS Excel. About Us: OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 30 years of experience in viral vectors; the driving force behind the majority of gene therapies. OXB collaborates with some of the worlds most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXBs world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise. Why Join Us? ???Competitive total reward packages ???Wellbeing programmes?that support your mental and physical health ???Career development opportunities?to help you grow and thrive ???Supportive, inclusive, and collaborative culture ???State-of-the-art labs and manufacturing facilities ??A company that lives its values:?Responsible, Responsive, Resilient, Respect We want you to feel inspired every day. At OXB,werefuture-focused and growing fast. We succeed togetherthrough passion, commitment, and teamwork. Ready to Make a Difference? Collaborate. Contribute. Change lives. We offer: Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 30 years of experience in viral vectors, the driving force behind the majority of gene therapies. Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patients cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy). Oxford Biomedica collaborates with some of the worlds most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedicas world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.